Neat News 1423 (added 2019-11-23)

Head and neck cancer treatment

cancerCells.jpg

In a trial it was found that treating head and neck cancer patients with pembrolizumab, an immunotherapy drug, can prolong their lives by two years. That is much longer than when treating them with chemotherapy.

News seen at: BBC - Health